UBS Group AG - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 48 filers reported holding OMEGA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,210
-66.5%
13,121
-12.8%
0.00%
Q2 2023$84,224
+244.5%
15,040
+271.0%
0.00%
Q1 2023$24,445
+160.4%
4,054
+146.6%
0.00%
Q4 2022$9,387
-53.1%
1,644
-54.4%
0.00%
Q3 2022$20,000
+900.0%
3,604
+1113.5%
0.00%
Q1 2022$2,000
-90.0%
297
-83.0%
0.00%
Q4 2021$20,000
+5.3%
1,752
+78.0%
0.00%
Q3 2021$19,0009840.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$758,8235.08%
Flagship Pioneering Inc. 29,225,579$62,834,9964.56%
HARBOURVEST PARTNERS LLC 3,512,110$7,551,0372.56%
CHI Advisors LLC 1,055,882$2,270,1460.90%
Knoll Capital Management, LLC 173,010$371,9710.39%
Artal Group S.A. 2,533,045$5,4460.23%
683 Capital Management, LLC 508,242$1,092,7200.08%
PLATINUM INVESTMENT MANAGEMENT LTD 887,017$1,907,0870.07%
ORACLE INVESTMENT MANAGEMENT INC 50,000$107,5000.03%
STATE OF WISCONSIN INVESTMENT BOARD 1,857,265$3,993,1200.01%
View complete list of OMEGA THERAPEUTICS INC shareholders